Location History:
- Stelle, DE (2006)
- Berlin, DE (2003 - 2009)
Company Filing History:
4 out of 1,384 
1 out of 2 
1 out of 192 
Years Active: 2003-2009
Title: Wolfgang Heil: Innovator in Pharmaceutical Compositions
Introduction
Wolfgang Heil is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceutical compositions, particularly in the development of estrogen-cyclodextrin complexes. With a total of 6 patents to his name, his work has had a considerable impact on the stability and efficacy of pharmaceutical formulations.
Latest Patents
His latest patents focus on compositions of estrogen-cyclodextrin complexes. These pharmaceutical compositions comprise low doses of sensitive complexes between an estrogen and a cyclodextrin, which are designed to provide improved stability. In specific embodiments, the composition includes a complex between ethinyl estradiol and β-cyclodextrin in a granulate preparation. Additionally, the composition may contain a limited amount of polyvinylpyrrolidone, as this excipient has been found to degrade ethinyl estradiol. Furthermore, Wolfgang Heil has developed methods for improving the stability of estrogen in these compositions and for manufacturing such stable formulations, emphasizing careful control of relative humidity during the granulate preparation process.
Career Highlights
Throughout his career, Wolfgang Heil has worked with prominent companies in the pharmaceutical industry, including Schering Aktiengesellschaft. His expertise in the field has allowed him to contribute to innovative solutions that enhance the stability and effectiveness of pharmaceutical products.
Collaborations
Wolfgang Heil has collaborated with notable colleagues such as Ralph Lipp and Thomas Backensfeld. These partnerships have further enriched his work and contributed to advancements in pharmaceutical sciences.
Conclusion
Wolfgang Heil's contributions to the field of pharmaceutical compositions, particularly through his patents on estrogen-cyclodextrin complexes, highlight his role as an innovator in the industry. His work continues to influence the development of stable and effective pharmaceutical formulations.